12:00 AM
Oct 08, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Status

Human neural stem cells: Phase I/II ongoing

StemCells said it began dosing in the second of 3 cohorts in an open-label Phase I/II trial evaluating HuCNS-SC in 12 SCI patients. The second cohort will enroll 4 patients with incomplete neurological injury classified as American Spinal Injury Association Impairment Scale (AIS) level...

Read the full 197 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >